← Back to Search

Other

monounsaturated fatty acids (MUFA) peanut meal for Healthy Aging (PIN Trial)

N/A
Recruiting
Led By Sue Shapses, PhD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline only
Awards & highlights

PIN Trial Summary

This trial will investigate how meals with different levels of saturated fatty acids affect inflammation and satiety in older adults. The study will compare a meal with peanuts, which are high in healthy fats, to

Who is the study for?
This trial is for older adults who are generally healthy but may be dealing with obesity. Participants should be interested in how different types of fats in their diet might affect inflammation and overall health as they age.Check my eligibility
What is being tested?
The study is testing the effects of a peanut meal rich in monounsaturated fatty acids (MUFA) compared to meals high in saturated fatty acids (SFA). It's designed to see if peanuts can help reduce inflammation after eating and improve feelings of fullness.See study design
What are the potential side effects?
Since this trial involves consuming peanut meals, potential side effects could include digestive discomfort or allergic reactions for those sensitive to nuts. However, no significant side effects are expected from MUFA-rich meals.

PIN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change over 6 hour mmt
This trial's timeline: 3 weeks for screening, Varies for treatment, and change over 6 hour mmt for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Concentration of Endotoxin
Concentration of Interleukin-6
Secondary outcome measures
Appetite
Concentration of Glucose and Insulin
Concentration of Inflammatory markers
+1 more
Other outcome measures
Characterization of the Microbiome
Concentration of Bone regulating markers
Concentration of incretin hormones
+2 more

PIN Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: monounsaturated fatty acids (MUFA) peanut mealExperimental Treatment1 Intervention
mixed meal test over 6 hours
Group II: saturated fatty acids (SFA) mealActive Control1 Intervention
mixed meal test over 6 hours

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,214 Total Patients Enrolled
3 Trials studying Healthy Aging
298 Patients Enrolled for Healthy Aging
Sue Shapses, PhDPrincipal InvestigatorRutgers, the State University of NJ
4 Previous Clinical Trials
247 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there ongoing efforts to actively enroll patients in this clinical trial?

"Affirmative. The information on clinicaltrials.gov indicates that this research is actively seeking participants. This trial was initially published on March 25, 2024, and the most recent update was made on March 30, 2024. A total of 18 subjects are being sought from two distinct locations for inclusion in this study."

Answered by AI

What is the upper limit in terms of patient enrollment for this medical study?

"Indeed, the details provided on clinicaltrials.gov highlight that recruitment is ongoing for this research. Initially shared on March 25th, 2024, with the most recent update made on March 30th, 2024, the study aims to enroll a total of 18 participants distributed across two medical facilities."

Answered by AI

What is the primary purpose of conducting this medical study?

"During the course of this clinical investigation, lasting approximately 6 hours, primary focus will be on monitoring Endotoxin Concentration. Secondary goals involve examining Glucose and Insulin levels measured in serum (mg/dL), Triglyceride concentration also assessed through serum analysis, as well as Appetite gauged using a visual analogue scale ranging from 0 (not at all) to 14 (extremely)."

Answered by AI
~12 spots leftby Oct 2024